baber/WOPTO huggingface dataset:
Patent AU-2004296157-B2 (AU)
Title: Device and method for filtering smoke
Inventor: GIDDING MARINUS THEODORUS FRANCISCUS MARIA
IPC: A24F7/04
Filed: 2004-12-13
Granted: 2010-11-11
Abstract: The present invention comprises a device for filtering tobacco smoke from a tobacco product, comprising a housing in which the tobacco product can be arranged, and a filter for filtering tobacco smoke, the housing comprising: 
- a tobacco reservoir for holding tobacco, 
- an outside air feed for feeding from the environment outside air necessary for the combustion of the tobacco, 
- a tobacco smoke discharge for discharging tobacco smoke caused by the combustion, 
- a filter connected to the tobacco smoke discharge for filtering substances harmful to the environment from the tobacco smoke; 
- a mouthpiece which is connected to the tobacco reservoir and the smoke discharge and with which a smoker can inhale the tobacco smoke from the tobacco reservoir and can exhale the tobacco smoke to the tobacco smoke discharge,  characterized in that  the filter comprises at least one of an absorption filter unit, an electrostatic filter unit, an ionization filter unit (76,101), a centrifugal filter unit, a UV filter unit or an ozone filter unit.
Patent AU-2004326202-B2 (AU)
Title: Microbiocidal control in the processing of meat-producing four-legged animals
Inventor: MCNAUGHTON JAMES L
IPC: A23L13/00
Filed: 2004-12-23
Granted: 2011-11-10
Abstract: Methods of processing four-legged slaughter animals for consumption as meat and/or meat product(s) are described. The methods comprise (I) contacting exterior surfaces of the live animal at least once when the animal is en route to being slaughtered but before it is killed by exsanguination, with a microbiocidal solution, or (II) contacting a carcass of the animal, after exsanguination, with a microbiocidal solution, or (III) contacting at least one raw meat product and/or at least one processed meat product derived from the carcass at least once with a microbiocidal solution, or (IV) conducting any two or all three of (I), (II), and (III). In each case the microbiocidal solution is, independently, comprised of: (a) water having a bromine residual derived from (i) at least one bromine source, (ii) at least one alkali metal base, and/or at least one alkaline earth metal base, and (iii) at least one halogen stabilizer; or (b) water having a bromine residual derived from (i) ammonium bromide, and/or at least one alkali metal bromide, and/or at least one alkaline earth metal bromide, and (ii) at least one alkali metal hypohalite and/or at least one alkaline earth metal hypohalite; or (c) water having a bromine residual derived from a mixture or combination of any one or more of (a) and any one or more of (b); the bromine residual in each of (a), (b), and (c) being sufficient to provide microbiocidal activity.
Patent AU-2005293811-B2 (AU)
Title: Fungicidal active ingredient combinations containing fluoxastrobin
Inventor: HEINEMANN ULRICH
IPC: A01N43/88
Filed: 2005-10-11
Granted: 2012-04-05
Abstract: The invention relates to active ingredient combinations, which consist of the known ingredient fluoxastrobin and additional known fungicidal active ingredients and which are extremely effective in controlling undesirable phytopathogenic fungi.
Patent AU-2005297061-B2 (AU)
Title: Method for the isolation of haptoglobin
Inventor: KUMPALUME PETER
IPC: C07K14/47
Filed: 2005-10-19
Granted: 2011-09-01
Abstract: The invention provides a method for the isolation of haptoglobin from a sample comprising Cohn fraction V, wherein said method comprises anion exchange chromatography of said sample. The product may be further purified and/or subjected to one or more virus inactivation or reduction steps. The isolated haptoglobin may then be formulated for pharmaceutical use.
Patent AU-2006200156-B2 (AU)
Title: Connector for plates, particularly for shelves or trays
Inventor: RUDIGER WALZ
IPC: F16B12/20
Filed: 2006-01-13
Granted: 2011-06-30
Abstract: A connector for plates, particularly for shelves or trays, includes a mounting member which is insertable into a recess of a first part, wherein a fastening member for a second part is insertable into the mounting member approximately in axial direction. A bolt or the like which is rotatable between a release position and a locking position is mounted in the mounting member, wherein a support member is provided between the bolt and the wall of the mounting member on the circumference of the bolt, and wherein the bolt and/or the support member have for pressing against each other a particularly arc-shaped thickened portion or at least a partially eccentric configuration. -1/O
Patent AU-2006201356-B2 (AU)
Title: Temperature regulating patient return electrode and return electrode monitoring system
Inventor: ARTS GENE H
IPC: A61B5/276
Filed: 2006-03-31
Granted: 2012-06-07
Abstract: TEMPERATURE REGULATING PATIENT RETURN ELECTRODE AND RETURN ELECTRODE MONITORING SYSTEM A temperature regulating patient return electrode (50) and return electrode monitoring system for use in monopolar surgery, includes a positive temperature coefficient (PTC) material disposed on its surface. The PTC material responds to local increases in temperature by increasing local resistance. This quality decreases the 10 probability of a patient (20) burn as a result of monopolar surgery. The return electrode monitoring system includes a generator (14) for generating current; an active electrode coupled to the generator for supplying the current to a patient; and a return electrode coupled to the generator with a surface for receiving the current from the patient and returning the current to the generator. A positive temperature coefficient (PTC) material is is disposed on the return electrode for regulating the temperature over the surface of the return electrode. -16 12-\ 1-----------
Patent AU-2006243565-B2 (AU)
Title: Method and apparatus for converting organic material
Inventor: BRUMMERSTEDT IVERSEN STEEN
IPC: B01J21/06
Filed: 2006-04-28
Granted: 2012-02-09
Abstract: The present invention relates to a method and apparatus for intensifying the energy content of an organic material by converting the material into hydrocarbons and the resulting product thereof. A method for converting an organic material into hydrocarbon fuels is disclosed. The method comprising the steps of pressurising said organic material being in a fluid to a pressure above 225 bar, heating said organic material in said fluid to a temperature above 200 C in the presence of a homogeneous catalyst comprising a compound of at least one element of group IA of the periodic table of elements. The disclosed method further comprises the steps of contacting said organic material in said fluid with a heterogeneous catalyst comprising a compound of at least one element of group IVB of the periodic table and/or alpha-alumina assuring that said fluid has initially a pH value of above 7.
Patent AU-2006267391-B2 (AU)
Title: N-dihydroxyalkyl-substituted 2-oxoimidazole derivative
Inventor: HIROKI SAKOH
IPC: A61P13/02
Filed: 2006-07-11
Granted: 2011-12-08
Abstract: It is intended to provide a compound represented by the formula (I) (I) (wherein R represents an alkyl group having 1 to 6 carbon atoms substituted with 2 hydroxyl groups, Cy represents a bicyclic or tricyclic aliphatic carbocyclic group having 6 to 10 carbon atoms which may have a substituent in some cases). The compound acts as a nociceptin receptor antagonist and is useful as, for example, a narcotic analgesic resistance reversal agent; a reversal agent for narcotic analgesic dependency or withdrawal syndrome; an analgesic action enhancing agent; an anti-obesity agent or an appetite control agent; an improving agent or preventive agent for decline in learning and memory abilities or dementia symptom; an improving agent for cognitive function in the developmental stage; a therapeutic agent for schizophrenia; a therapeutic agent for regressive neurodegenerative disease; an antidepressant agent or an emotion control agent; a therapeutic agent or preventive agent for diabetes insipidus; a therapeutic agent or preventive agent for polyuria; a therapeutic agent for hypopiesis and the like.
Patent AU-2006298641-B2 (AU)
Title: Liquid-heating device for electric household appliance
Inventor: MEYER PASCAL
IPC: A47J31/54
Filed: 2006-10-04
Granted: 2010-02-25
Abstract: Liquid-heating device (11) for an electric household appliance, the device comprising a main body (1) and a complementary element (3) disposed opposite a face of the main body (1), a liquid circulation channel (4) existing between the complementary element (3) and main body (1), said channel having two ends forming an inlet (5) designed to be connected to a liquid reservoir and an outlet (6) designed for discharging the heated liquid, said complementary element (3) having a heating resistor (2) disposed in order to enable the heating of liquid travelling along the channel (4). Said channel (4) has a minimum cross-sectional liquid flow area (5 min) situated distant from said outlet (6) and within closer proximity to the outlet (6) of the channel than to the inlet (5) thereof.
Patent AU-2006315512-B2 (AU)
Title: Administration of an mTOR inhibitor to treat patients with cancer
Inventor: BEDROSIAN CAMILLE L
IPC: A61K31/436
Filed: 2006-11-14
Granted: 2012-11-01
Abstract: The invention features methods for treatment of a patient in need thereof with the administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus, temsirolimus, everolimus or rapamycin analogs including AP23573, especially to a cancer patient for 4 or 5 consecutive days per week. The mTOR inhibitor therapy can be used for a wide range of cancers including prostrate, pancreas, ovary, lung, breast, bladder, colon, brain, head and neck, endometrium, leukemia, lymphoma and sarcoma.
Patent AU-2006340316-B2 (AU)
Title: High-calorie nutritional supplement
Inventor: GREENBERG NORMAN ALAN
IPC: A23L33/00
Filed: 2006-10-18
Granted: 2013-03-28
Abstract: The invention provides a nutritional supplement comprising a protein source including milk protein isolate and/or canola plant protein, as well as related methods for its production and use in treating a nutritional deficiency in an individual.
Patent AU-2007224669-B2 (AU)
Title: Pegylated mutated clostridium botulinum toxin
Inventor: FREVERT JURGEN
IPC: C07K14/33
Filed: 2007-03-15
Granted: 2010-05-13
Abstract: Modified botulinum toxin (BoNT) which exhibits a natural heavy chain and a modified light chain, where the light chain is modified at its N terminal end that exhibits a chain extension in the direction from the N- to the C-terminal end. Modified botulinum toxin (BoNT), which exhibits a natural heavy chain and a modified light chain, where the light chain is modified at its N terminal end that exhibits a chain extension in the direction from the N- to the C-terminal end, with a structure of (-(Cy) n-(tag) m-(X) l). Cy : cysteine residue, where at least one of the cysteine residues in the chain extension is coupled to at least a chain polyethylene glycol; tag : any tag, preferably histidine tag or streptavidin tag; X : any naturally occurring amino acid; n : 1-50; m : 0 or 1; and l : 0-50. Independent claims are included for: (1) a composition for human and/or veterinary medicine comprising the modified botulinum toxin; (2) a nucleic acid which codes for the modified botulinum toxin; (3) a vector comprising the nucleic acid; and (4) a host cell comprising the vector. ACTIVITY : Muscular-Gen; Neuroprotective; Muscle-Relaxant; Antiinflammatory; Gastrointestinal-Gen; Inotropic; Dermatological. MECHANISM OF ACTION : None given.
Patent AU-2007230011-B2 (AU)
Title: System for supporting a rollable object
Inventor: VAN BELKOM ARNOLDUS
IPC: B60P7/12
Filed: 2007-03-23
Granted: 2012-06-14
Abstract: A system (1) for supporting a rollable object (4), such as a cylindrical container. The system comprises at least one elongated rail (2) and at least one supporting part. The rail (2) has a contact surface (6) for bearing on a base, and is furthermore provided, along at least two sides, with an at least partly profiled surface (5) for holding a supporting part (3) in position at least in a longitudinal direction of said elongated rail (2). The supporting part (3) comprises a supporting surface (7) for preventing a movement of the object (4) in a horizontal direction, and, optionally, for supporting the object (4) in a vertical direction, and a contact surface (8) for bearing on the rail (2) and/or the base. The supporting part (3) further comprises a passage (9) for receiving at least a part of the rail (2). This passage (9) is provided with an inner wall which is at least partly provided with a profiled surface (10) complementary to the profiled surface (5) of the two sides of the rail (2), for at least partly transmitting a force, applied to the supporting part in said longitudinal direction, to the rail (2).
Patent AU-2007262668-B2 (AU)
Title: A shelving system
Inventor: NEWBERY MAURICE GEORGE
IPC: A47B96/00
Filed: 2007-06-22
Granted: 2013-10-10
Abstract: A shelving system comprising a wall bracket having a wall attachment portion and a wall connecting portion; and a shelf bracket having a shelf attachment portion and a shelf connecting portion; wherein the wall connecting portion and the shelf connecting portion interlock.
Patent AU-2007263351-B2 (AU)
Title: Tablets comprising candesartan cilexetil
Inventor: ROEHRICH TILLMANN
IPC: A61K9/20
Filed: 2007-06-14
Granted: 2013-02-07
Abstract: Composition in the form of a tablet, comprising candesartan cilexetil and optionally further active agents and usual adjuncts, wherein the surface of at least the active agent candesartan cilexetil in this composition is provided with a coating, made from a compound or a mixture of compounds selected from tri-(C
Patent AU-2007267833-B2 (AU)
Title: Composition and methods for treatment of congestive heart failure
Inventor: JODKA CAROLYN M
IPC: C07K14/605
Filed: 2007-05-25
Granted: 2012-07-26
Abstract: Provided herein is the use of GLP-1 molecules or agonists and analogs thereof, and the use of exendin molecules or agonists and analogs thereof, including their derivatives and active fragments, for the prevention or treatment of congestive heart failure. Pharmaceutical compositions for use in the methods described herein are also disclosed. Further provided are compositions and methods for the treatment and/or prevention of diabetes mellitus, hyperglycemia, insulin resistance and obesity, and for the reduction of food intake and suppression of appetite of subjects.
Patent AU-2007288114-B2 (AU)
Title: A lice comb
Inventor: MAOR MOSHE
IPC: A45D24/00
Filed: 2007-08-23
Granted: 2012-04-05
Abstract: A lice comb (10) including a plurality of teeth (14) for capturing lice when the teeth (14) are passed through hair. The lice comb (10) is provided with a receptacle (22) including an adhesive inner surface and a means for moving lice captured by the teeth (14) into the receptacle (22) such that the lice come into contact with the adhesive surface, preventing escape of the lice.
Patent AU-2007345158-B2 (AU)
Title: Methods and apparatus to facilitate cooling syngas inside a gasifier
Inventor: WALLACE PAUL STEVEN
IPC: C10J3/86
Filed: 2007-12-20
Granted: 2012-12-06
Abstract: A method of cooling syngas in a gasifier (200) is provided. The method includes channeling cooling fluid (308) through at least one platen (320) that extends at least partially through a reaction zone (228) of the gasifier, and circulating reactant fluid around the at least one platen to facilitate heat transfer from the reactant fluid to the cooling fluid.
Patent AU-2008200383-B2 (AU)
Title: Surgical stapling apparatus with locking mechanism
Inventor: SCIRICA PAUL A
IPC: A61B17/03
Filed: 2008-01-25
Granted: 2013-05-23
Abstract: SURGICAL STAPLING APPARATUS WITH LOCKING Abstract The present disclosure provides for a surgical stapling apparatus (10) and/or a 5 loading unit (16) for use with and/or supportable on a distal end of a surgical stapling apparatus (10). The loading unit (16) includes a housing portion (200) including a distal end and a proximal end, a drive assembly (212) slidably supported within the housing portion (200) of the loading unit (16), and a locking mechanism (288) supported on the housing portion (200) of the loading unit (16). The locking mechanism (288) has a first to position wherein the locking mechanism (288) engages the drive assembly (212) and maintains the position of the drive assembly (212) in a ready-to-load position relative to the housing portion (200) of the loading unit (16). The locking mechanism (288) is pivotable to a second position wherein the locking mechanism (288) disengages the drive assembly (212) and enables the drive assembly (212) to move relative to the housing 15 portion (200).
Patent AU-2008230024-B2 (AU)
Title: Surface mountable integrated circuit packaging scheme
Inventor: DOAN CHINH HUY
IPC: H05K1/02
Filed: 2008-10-20
Granted: 2015-08-13
Abstract: An integrated circuit (IC) package is disclosed. The IC package includes a substrate having top, middle and bottom layers, an array of millimeter-wave antennas embedded on the top layer of the substrate and a monolithic microwave integrated circuit (MMIC) mounted on the bottom layer of the substrate. In one embodiment, the second level interconnect for surface-mounting on a printed circuit board (PCB) is provided on the bottom layer of the substrate. I fl C:(IZ
Patent AU-2008240105-B2 (AU)
Title: Safety syringe
Inventor: WOEHR KEVIN
IPC: A61M5/32
Filed: 2008-04-14
Granted: 2014-01-09
Abstract: Syringe assemblies are described with at least two co-axially positioned cylinders that move relative to one another by action of a spring. Aspects of the syringe assemblies include a protective unit in which a first cylinder of a first length is attached to a second cylinder of shorter second length. In different embodiments, a protective unit is formed of a single or singularly fabricated cylinder. The different protective units may be used with a syringe in which action of a plunger to push a plunger tip into contact with a distal wall of the syringe cylinder to discharge fluid located inside the syringe but does not immediately release the protective unit relative to the syringe cylinder to shield a needle.
Patent AU-2008245677-B2 (AU)
Title: Door closer assembly
Inventor: WEEPIE KEITH JAMES
IPC: E05F3/12
Filed: 2008-04-24
Granted: 2012-08-16
Abstract: A door closer assembly is provided, including a valve regulating an amount of hydraulic fluid that flows through the valve. The amount of hydraulic fluid flowing through the valve controls a force generated by the door closer assembly on a door. A first sensor measures an angular position of the door, and a second sensor measures an angular position of the valve. The angular position of the valve determines the amount of hydraulic fluid flowing through the valve. A controller controls the adjustment of the valve based on the angular position of the door and the angular position of the valve.
Patent AU-2008324243-B2 (AU)
Title: 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
Inventor: MOGI MUNETO
IPC: C07D401/14
Filed: 2008-11-03
Granted: 2012-03-08
Abstract: The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R5, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
Patent AU-2008326549-B2 (AU)
Title: Methods and apparatus for providing an efficient frame structure for wireless communication systems
Inventor: MAKHIJANI MAHESH
IPC: H04B7/26
Filed: 2008-11-14
Granted: 2012-02-09
Abstract: Providing for an efficient frame structure for wireless communication is disclosed, which may include frequency division multiplexing (FDM) first and second air interfaces in a downlink subframe of a frame, and may also include time division multiplexing (TDM) the first and second air interfaces in an uplink subframe of the frame.
Patent AU-2008340261-B2 (AU)
Title: HCV protease inhibitors and uses thereof
Inventor: KLUGE ARTHUR F
IPC: A01N43/36
Filed: 2008-12-19
Granted: 2015-06-11
Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Patent AU-2009212935-B2 (AU)
Title: Method and apparatus for facilitating a persistence application programming interface
Inventor: COLLINS JEFFREY M
IPC: G06F17/30
Filed: 2009-09-02
Granted: 2015-07-16
Abstract: [00921 One embodiment of the present invention provides a system for implementing a persistence application programming interface (API) that is platform independent and can make up-calls to business logic. During operation, the system receives a request at the API to execute a command at a persistence tier of an n-tier distributed application. In response to the request, the system determines an entity type for an ertity affected by the command. Next, the system identifies a function at a middle tier of the n-tier distributed application that is associated with the entity type and the command, wherein the middle tier includes the business logic. The system then sends an instruction to the middle tier to execute the function. Finally, upon receiving a confirmation at the API that the function executed, the system executes the command at the persistence tier. START; RECEIVE REQUEST AT API TO TO EXECUTE A COMMAND AT A PERSISTENCE TIER OF AN n-TIER DISTRIBUTED APPLICATION DETERMINE AN ENTITY TYPE FOR AN ENTITY AFFECTED BY THE COMMAND IDENTIFY A FUNCTION AT A MIDDLE-TIER OF THE n-TIER DISTRIBUTED APPLICATION THAT IS ASSOCIATED WITH THE ENTITY TYPE AND THE COMMAND START A TRANSACTION SEND AN INSTRUCTION TO THE MIDDLE TIER TO EXECUTE THE FUNCTION EXECUTE THE COMMAND AT THE PERSISTENCE TIER UPON RECEIVING A CONFIRMATION THE THE FUNCTION COMMIT THE TRANSACTION
Patent AU-2009218828-B2 (AU)
Title: Method and reactor for the preparation of methanol
Inventor: THORHAUGE MAX
IPC: B01J8/02
Filed: 2009-02-12
Granted: 2013-01-17
Abstract: Improved design of a catalytic method and reactor for the production of methanol at equilibrium conditions whereby methanol as it is formed is separated from the gaseous phase into the liquid phase within the reactor without reducing the catalytic activity of the methanol catalyst. This is achieved by adjusting the boiling point or temperature of a liquid cooling agent being in indirect contact with the catalyst particles and by providing a specific ratio of catalyst bed volume to cooling surface area. Thereby, condensation of methanol as it is formed in the gaseous phase takes place for the most at the cooling surface arranged evenly distributed within the reactor and if at all within a very limited region of the catalyst bed.
Patent AU-2009225323-B2 (AU)
Title: Pyridylsulfonamido pyrimidines for treating diabetic nephropathy
Inventor: JESSICA MANN
IPC: A61P13/12
Filed: 2009-10-14
Granted: 2011-11-24
Abstract: Abstract Pyridylsulfonamido Pyrimidines for Treating Diabetic Nephropathy 5 (0)f The present invention relates to the use of a compound of formula (I) wherein R, is pyridyl or thiazolyl, any of which may optionally be substituted with Ci-salkyl or C2-8alkenyl; and a) R2 is methoxy and n is zero or one; or b) R2 is chlorine and n is zero and pharmaceutically acceptable salts thereof for lowering or controlling io proteinuria, in particular for the treatment of diabetic nephropathy.
Patent AU-2009244341-B2 (AU)
Title: Method of measuring effects of components on cell reactive oxygen species production
Inventor: TRIVEDI HARSH M
IPC: G01N33/50
Filed: 2009-05-06
Granted: 2012-01-19
Abstract: A method of determining the effects of a test component on intracellular ROS levels. The method can be used in marketing or in screening for useful components in reducing ROS levels in cells adversely affected by increased ROS generation.